reports
STEALTHGAS INC. Announces the Date for the Release of the First Quarte...
STEALTHGAS INC. Announces the Date for the Release of the First Quarter 2024 Financial and Operating Results, Conference Call and Webcast ATHENS, Greece, May 17, 2024 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its first quarter operating and financial results for the period ended March 31, 2024 before the market opens in New York on May 22, 2024. On May 22, 2024 at 11:00 am ET, the company’s management will host a con...
Great Elm Capital Corp. Announces First Quarter 2024 Financial Results
Great Elm Capital Corp. Announces First Quarter 2024 Financial Results Company to Host Conference Call and Webcast at 5:00 PM ET Today PALM BEACH GARDENS, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC”) (NASDAQ: GECC), a business development company, today announced its financial results for the first quarter ended March 31, 2024. First Quarter and Other Recent Highlights: In February 2024, the Company raised $24 million of equity at Net Asset Value from a special purchase vehicle (“SPV”), supported by a $6 million investm...
Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2024 Earnings...
Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2024 Earnings Release and Conference Call Conference Call Scheduled for Thursday, May 2, 2024 at 5:00 p.m. ET PALM BEACH GARDENS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ: GECC), a business development company, today announced it will release its financial results for the first quarter ended March 31, 2024 after the close of market trading on Thursday, May 2, 2024, and discuss these results in a conference call at 5:00 p.m. ET. Date/Time:Thursday, May 2, 2024 – 5:00 p....
Great Elm Capital Corp. Prices Public Offering of $30,000,000 of 8.50%...
Great Elm Capital Corp. Prices Public Offering of $30,000,000 of 8.50% Notes Due 2029 PALM BEACH GARDENS, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today the pricing of its underwritten public offering of $30,000,000 aggregate principal amount of its 8.50% notes due 2029 (the “Notes”), which will result in net proceeds to the Company of approximately $28.6 million after payment of underwriting discounts and commissions and estimated offering expenses payable by the Company. The Notes will mature on April 30, 2029...
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes
Great Elm Capital Corp. Announces Public Offering of Unsecured Notes PALM BEACH GARDENS, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”) (NASDAQ: GECC) announced today the commencement of an underwritten public offering of unsecured notes due 2029 (the “Notes”). The Notes are expected to be listed on The Nasdaq Global Market under the trading symbol “GECCI,” and to trade thereon within 30 days from the original issue date. The interest rate and other terms of the Notes will be determined by negotiations between the Company and the underwriters. ...
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Off...
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee – Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned cancer institutions – BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline on March 25 by AVEO Pharmaceuticals, the text in the second paragraph has been corrected to better reflect Dr. Braendle's clinical research experience. The corrected r...
- Dave Nicoski
- Ross LaDuke
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
PRTA PROTHENA CORP. PLC
NTRS NORTHERN TRUST CORPORATION
KMB KIMBERLY-CLARK CORPORATION
KHC KRAFT HEINZ COMPANY
CRK COMSTOCK RESOURCES INC.
COG CABOT OIL & GAS CORPORATION
BGS B&G FOODS INC.
AR ANTERO RESOURCES CORPORATION
AAP ADVANCE AUTO PARTS INC.
REI REIBEL
ELY CALLAWAY GOLF COMPANY
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
TG TREDEGAR CORP.
NNI NELNET INC. CLASS A
AA ALCOA CORPORATION
CTVA CORTEVA INC
RVLV REVOLVE GROUP
BALY BALLYS CORPORATION
VHI VALHI INC.
APA APA CORPORATION
SWIM LATHAM GROUP INC
ALTG ALTA EQUIP GROUP INC
DO DIAMOND OFFSHORE DRILLING INC.
XPOF XPONENTIAL FITNESS INC
AVO THE AVEON GROUP LP
Moody's changes Matador's outlook to positive, rates proposed unsecure...
Moody's Ratings ("Moody's") assigned a B1 rating to Matador Resources Company's (Matador) proposed senior unsecured notes due 2032. Moody's concurrently changed the company's rating outlook to positive from stable, and affirmed its Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rat...
AVEO Oncology Announces Appointment of Chief Medical Officer and Forma...
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee – Industry veteran brings extensive clinical development experience to AVEO Oncology leadership team as Chief Medical Officer – – Formation of a Scientific Advisory Committee from world-renowned cancer institutions – BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer. Dr. Braendle is a life sciences executive with ex...
Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2023 Fi...
Great Elm Capital Corp. Announces Fourth Quarter and Full Year 2023 Financial Results Company to Host Conference Call and Webcast at 8:30 AM ET Today PALM BEACH GARDENS, Fla., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (“we,” “our,” the “Company” or “GECC,”) (NASDAQ: GECC), a business development company, today announced its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Other Recent Highlights: In February 2024, the Company raised $24 million of equity at Net Asset Value from a special purchase vehicle (“SPV”), supp...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
U.S. Dollar (DXY) Rolling Over Large-cap indexes (S&P 500, Nasdaq 100, and DJI) remain bullish, all hitting new all-time highs last week while continuing to find short-term support at their respective 20-day MAs. Mid-caps (S&P 400, Russell Mid-Cap) are starting another leg higher following breakouts from 2-month consolidations. Small-caps (S&P 600, Russell 2000) are likely to follow in the footsteps of large- and mid-caps, and are likely to break out from their 2.5-month consolidations/high bas...
WWW WOLVERINE WORLD WIDE INC.
TEVA.N TEVA PHARMACEUTICAL INDUSTRIES LIMITED SPONSORED ADR
SHOO STEVEN MADDEN LTD.
RCKY ROCKY BRANDS
MAR MARRIOTT INTERNATIONAL INC. CLASS A
H HYATT HOTELS CORPORATION CLASS A
GPS GAP INC.
ANF ABERCROMBIE & FITCH CO. CLASS A
AEO AMERICAN EAGLE OUTFITTERS INC.
TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
WEYS WEYCO GROUP INC.
HGV HILTON GRAND VACATIONS INC.
HLT HILTON WORLDWIDE HOLDINGS INC
AMRX AMNEAL PHARMACEUTICALS INC. CLASS A
HTHT HUAZHU GROUP LTD. SPONSORED ADR
VTRS VIATRIS INC.
IHG INTERCONTINENTAL HOTELS GROUP
Great Elm Capital Corp. (“GECC”) Schedules Fourth Quarter and Full Yea...
Great Elm Capital Corp. (“GECC”) Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Conference Call Scheduled for Thursday, February 29, 2024 at 8:30 a.m. ET PALM BEACH GARDENS, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ: GECC), a business development company, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2023 prior to the opening of the stock market on Thursday, February 29, 2024, and discuss these results in a conference call at 8:30 a....
STEALTHGAS INC. Reports Fourth Quarter and Twelve Months 2023 Financia...
STEALTHGAS INC. Reports Fourth Quarter and Twelve Months 2023 Financial and Operating Results ATHENS, Greece, Feb. 21, 2024 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today its unaudited financial and operating results for the fourth quarter and twelve months ended December 31, 2023. OPERATIONAL AND FINANCIAL HIGHLIGHTS All-time record Net Income of $51.9 million for the twelve-month period, a 51% increase compared to last year, corresponding ...
STEALTHGAS INC. Announces the Date for the Release of the Fourth Quart...
STEALTHGAS INC. Announces the Date for the Release of the Fourth Quarter and Twelve Months 2023 Financial and Operating Results, Conference Call and Webcast ATHENS, Greece, Feb. 15, 2024 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS) (the “Company”), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today that it will release its fourth quarter operating and financial results for the period ended December 31, 2023 before the market opens in New York on February 21, 2024. On February 21, 2024 at 11:00 am ET, the co...
Great Elm Capital Corp. (“GECC”) Raises $24 Million of Equity at Net A...
Great Elm Capital Corp. (“GECC”) Raises $24 Million of Equity at Net Asset Value Provides Preliminary Fourth Quarter 2023 Financial Results; Declares First Quarter 2024 Distribution of $0.35 per Share PALM BEACH GARDENS, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Great Elm Capital Corp. (the “Company” or “GECC”), (NASDAQ: GECC), a business development company, today announced it issued approximately 1.85 million shares of the Company’s common stock at a current net asset value of $12.97 per share to a special purpose vehicle for an aggregate gross purchase price of $24 million (the “Transa...
AVEO Oncology Announces Publication of Long-Term Survival in Patients ...
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist BOSTON, Feb. 06, 2024 (GLOBE NEWSWIRE) -- , an LG Chem company (“AVEO”), today announced The Oncologist has published a post-hoc analysis of long-term progression free survival, overall survival and safety data from the Phase 3 TIVO-3 trial evaluating FOTIVDA® (tivozanib) in patients with relapsed or refractory (R/R) advanced renal cell carcinoma (RCC). In the publication, FOTIVDA demo...
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Tria...
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Phase 3 Registrational Trial Seeks to Improve Survival Outcomes in Underserved HPV-negative R/M Head and Neck Cancer Patient PopulationTrial Launch Follows FDA Fast Track Designation of Ficlatuzumab/cetuximab Combination for Treatment of Relapsed/Recurrent HNSCC BOSTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.